U Testa1, E Montesoro, D Bulgarini
1Laboratorio di Ematologia ed Oncologia, Istituto Superiore di Sanità, Rome, Italy.
Interleukin-2 (IL-2) is a cytokine used in cancer immunotherapy. Its antitumor effects in cancer therapy appear to involve indirect immune system mechanisms.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: